tirzepatide vs semaglutide safety profile Comparative efficacy and of 2.4 mg and 5–15 mg in obesity with or without type 2 diabetes: A systematic review of Phase 3 clinical trials Comparing Tirzepatide vs Semaglutide: Effects,

This publication has not received compensated product samples for testing, has not interviewed Trimi or Arora Health personnel, has not been granted access to internal product specifications beyond what is publicly published, and has not conducted independent laboratory or clinical testing of any compounded medication

Reduction of Body Fat: Helps reduce both visceral and subcutaneous fat for a more balanced body contour

Li, H.X

The goal is a plan that is realistic, safe, and sustainable

Study participants were clinically overweight and had cardiovascular disease, and were randomly assigned to receive weekly injections of semaglutide or a placebo